A review of the literature indicates that the 5-year survival rate within a broad range of 4.5-48%, but a large cluster occurs at 10-25%
The approved indication specifies that Wegovy is for adults with: BMI of 30 kg/m or greater (obesity), OR BMI of 27 kg/m or greater (overweight) with at least one weight-related comorbidity Weight-related comorbidities specified in the approval include hypertension, Type 2 diabetes, and dyslipidemia (abnormal cholesterol or triglyceride levels)
The immune system as a Article Earthworms, Enzymes, and Circulation: The Science Behind Lumbrokinase Blood clotting is essential for healing and other important functions throughout the body, but when the process goes unchecked, it may have long-term implications Article Mitochondria: The Overlooked Link in the Gut-Brain Axis The gut-brain axis is well-established, but theres more to this dynamic relationship than meets the eye
IMPORTANT: Please ensure your mail program is configured to accept email from [email protected] sender, add our email to your non blocked email address so we may send invoices, order status and shipping confirmations
Scientific evidence underlying contraindications to the ketogenic diet: an update
Red Bull is an acidic beverage
